Examples of using Cmax in English and their translations into Danish
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
In the fed state, Cmax was lower(22% rosiglitazone
See section 4.2 increased Cmax and AUCτ of phenytoin(300 mg once daily) by 67% and 81%, respectively.
Saquinavir AUC↓ 15% Saquinavir Cmax↓ 9% Saquinavir Cmin↓ 24% remained above the target threshold for effective therapy.
Nevirapine AUC↑ 1.26 Nevirapine Cmin↑ 1.28 Nevirapine Cmax↑ 1.24 compared to historical controls.
Nevirapine AUC↓ 0.42 Nevirapine Cmin↓ 0.32 Nevirapine Cmax↓ 0.50 compared to historical controls.
When used in conjunction with an increase in the duration of a meal period reaching Cmax(two hours) and its reduction of about16.
Saquinavir AUC↑ 177% Saquinavir Cmax↑ 187% Clarithromycin AUC↑ 40% Clarithromycin Cmax↑ 40%- Interaction with Invirase/ ritonavir not studied.
Saquinavir AUC↓ 51% Saquinavir Ctrough↓ 49%(8 hours post dose) Saquinavir Cmax↓ 54.
Although safety was not compromised in this population dose adjustment may be required in view of low Cmax.
range as those in older children, though higher Cmax levels are likely to be observed in some children with a body weight below 10 kg.
Plasma ara-G Cmax values generally occurred at the end of the nelarabine infusion and were generally higher than nelarabine Cmax values, suggesting rapid
plasma nelarabine Cmax and AUCinf values were 13.9 µM(81%) and 13.5 µM. h(56%) respectively.
Saquinavir AUC↑ 60% Saquinavir Cmax↑ 42% Ritonavir AUC↑ 41% Ritonavir Cmax↑ 34% Atazanavir↔ No clinical data available for the combination of saquinavir/ ritonavir 1000/ 100 mg bid and atazanavir.
Midazolam AUC↑ 12.4 fold Midazolam Cmax↑ 4.3 fold Midazolam t1/ 2↑ from 4.7 h to 14.9 h No data are available on concomitant use of ritonavir boosted saquinavir with intravenous midazolam.
based on comparison of Cmax values at the No Observed Effect Level(NOEL) with the Cmax achieved on dosing with 6 mg/ kg once daily in patients with normal renal function.
However, lower peak serum levels(Cmax) are achieved.
As demonstrated by the bioequivalence in systemic levels AUC and Cmax.
Preliminary data suggest that irbesartan may decrease Rasilez AUC and Cmax.
There is a linear relationship between dose and both Cmax and AUC.